Posters/Exhibits/Break > Session
Posters/Exhibits/Break
Presentations
A1. ANTICOAGULATION CLINICS | |||||
|
(201) LONGITUDINAL CHANGES IN HEALTH-RELATED QUALITY OF LIFE (HRQL) DURING ANTICOAGULATION THERAPY IN CANCER-ASSOCIATED VENOUS THROMBOEMBOLISM TREATMENT Taylor A Hopper1, Eva Ordonez Mazariegos2, Andrea Jimena Morales Arteaga3, Cristhiam M Rojas Hernandez2. 1The University of Texas Health Science Center at Houston, Houston, TX, USA 2The University of Texas MD Anderson Cancer Center, Houston, TX, USA 3Tecnologico de Monterrey, School of Medicine and Health Sciences, Monterrey, Mexico |
||||
A2. PLATELET ACTIVATION AND BIOCHEMISTRY | |||||
|
(202) PLATELET INDICES IN HEALTHY PREGNANCIES Laura M. Dionisio, Giovani M. Favero. State University of Ponta Grossa, Ponta Grossa, Brazil |
||||
A4. DISORDERS OF PLATELET NUMBER OR FUNCTION | |||||
|
(203) PREVALENCE AND OUTCOMES OF HEPARIN-INDUCED THROMBOCYTOPENIA IN INFLAMMATORY BOWEL DISEASE: A DECADE STUDY Ayobami Olafimihan1, Ekrem Turk1, Praise fawehinmi2, Gbolahan Olatunji3, Emmanuel Kokori3, Aderinto Nicholas 4, Alejandro Vallejo1, Nkechi Akata5, Shaka Hafeez1. 1John H. Stroger Jr Hospital, Chicago, IL, USA 2Southern Illinois University Edwardsville, Edwardsville, IL, USA 3University of Ilorin, Ilorin, Nigeria 4Ladoke Akintola University of Technology, Ogbomosho, Nigeria 5Meharry Medical College, Nashville, TN, USA |
||||
A5. BLOOD COAGULATION AND FIBRINOLYTIC FACTORS | |||||
|
(204) FIXED-DOSING OF 4-FACTOR PROTHROMBIN COMPLEX CONCENTRATE FOR REVERSAL OF ANTICOAGULATION: EVALUATING THE EFFECTIVENESS, SAFETY, AND COST SAVINGS Amer Al Homssi1, Ryan Lokkesmoe1, Ryan Powers1, Benjamin Jung2, Lisa Baumann Kreuziger3. 1Medical College of Wisconsin, Milwaukee, WI, USA 2Froedtert Health, Milwaukee, WI, USA 3Versiti Blood Research Institute, Milwaukee, WI, USA |
||||
|
(205) STRUCTURED EDUCATION FOR NEWLY DIAGNOSED PERSONS WITH VON WILLEBRAND DISEASE: A HEMOPHILIA TREATMENT CENTER QUALITY IMPROVEMENT PROJECT ABSTRACT Dominique N. Barclay, Sarah E. Gonzales, Marsha Hurn, Amanda Kilgore, Jesla Ryan, Jonathan C. Roberts, Michael D. Tarantino. Bleeding and Clotting Disorders Institute, Peoria, IL, USA |
||||
A6. DISORDERS OF COAGULATION OR FIBRINOLYSIS | |||||
|
(206) SAFETY AND EFFICACY OF THE ANTI-TISSUE FACTOR PATHWAY INHIBITOR MARSTACIMAB IN PARTICIPANTS WITH SEVERE HEMOPHILIA WITHOUT INHIBITORS: RESULTS FROM THE PHASE 3 BASIS TRIAL AND ONGOING LONG-TERM EXTENSION STUDY Suchitra S. Acharya1, Davide Matino2, Andrew Palladino3, Eunhee Hwang3, Regina McDonald4, Carrie Turich Taylor5, John Teeter5. 1Cohen Children's Medical Center, Northwell Hemostasis and Thrombosis Center, Northwell Health, New Hyde Park, NY, USA 2McMaster University, 237 Barton St. East, Hamilton, ON, Canada 3Pfizer Inc, Collegeville, PA, USA 4Pfizer Inc, New York, NY, USA 5Pfizer Inc, Groton, CT, USA |
||||
|
(207) EFFICACY AND SAFETY OF EPTACOG BETA FOR BLEED TREATMENT IN ADULTS AND ADOLESCENTS WITH HEMOPHILIA B AND INHIBITORS DURING PERSEPT 1 Meera Chitlur1, Yasmina Abajas2, Suchitra Acharya3, Sanjay Ahuja4, Jonathan Bernstein5, Elizabeth Bowhay-Carnes6, Brandon Hardesty7, Jonathan C. Roberts8,9, Vanessa Salinas10, Craig Seaman11, Robert Sidonio Jr.12, Daniel Bonzo13, Jim Phipps14, Thomas Wilkinson15, Guy Young16. 1Central Michigan University College of Medicine/Children’s Hospital of Michigan, Carmen and Ann Adams Department of Pediatrics, Division of Hematology/Oncology, Detroit, NY, USA 2Hemophilia and Thrombosis Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA 3Cohen Children’s Medical Center, Northwell Health, New Hyde Park, NY, USA 4Rainbow Babies & Children’s Hospital, Cleveland, OH, USA 5Hemophilia Center of Central Pennsylvania, Hershey Medical Center, Hershey, PA, USA 6UT Health San Antonio, San Antonio, TX, USA 7Indiana Hemophilia & Thrombosis Center, Indianapolis, IN, USA 8Bleeding & Clotting Disorders Institute, Peoria, IL, USA 9Departments of Pediatrics and Medicine, University of Illinois College of Medicine at Peoria, Peoria, IL, USA 10Center for Inherited Blood Disorders, Orange, CA, USA 11Hemophilia Center of Western Pennsylvania, Pittsburgh, PA, USA 12Aflac Cancer and Blood Disorders Center and Emory University, Atlanta, GA, USA 13LFB-USA, Inc., Framingham, MA, USA 14HEMA Biologics, LLC, Louisville, KY, USA 15GLOVAL LLC, Broomfield, CO, USA 16Children's Hospital Los Angeles and Keck School of Medicine, University of Southern California, Los Angeles, CA, USA |
||||
|
(208) ACCESS TO FACTOR VIII AND FACTOR IX TO PERSONS WITH HEMOPHILIA IN ARKANSAS: A QUALITY IMPROVEMENT STUDY Divyaswathi Citla-Sridhar1, 2, Kara Burge2, Jean Aroom3, Justine Kaplan3, Shelley Crary1, 2. 1University of Arkansas for Medical Sciences, Little Rock, AR, USA 2Arkansas Children’s Hospital, Little Rock, AR, USA 3American Thrombosis and Hemostasis Network, Rochester, NY, USA |
||||
|
(209) DISEASE BURDEN, QUALITY OF LIFE, AND TREATMENT PATTERNS IN PATIENTS WITH HEREDITARY FACTOR X DEFICIENCY: ANALYSIS OF DATA FROM THE HEREDITARY FACTOR X DEFICIENCY IN AMERICA SURVEY Kim Clark1, Denise A. Garner2, Amy Wu2, Lorie Mody2, Jaymin Patel2, Brian Branchford3. 1Kedrion Biopharma, INC., Fort Lee, NJ, USA 2AESARA, INC., Chapel Hill, NC, USA 3Versiti Blood Research Institute, Medical College of Wisconsin, and Children's Wisconsin, Milwaukee, WI, USA |
||||
|
(210) ELEVATED PROTEIN C IS PROTECTIVE AGAINST POST THROMBOTIC SYNDROME Zijun He1, Vivian Thompson1, Dianne Thornhill1, Rick Shearer1, Christine Baird2, Marilyn Manco-Johnson1. 1University of Colorado Anschutz Medical Campus, Aurora, CO, USA 2University of Colorado Anschutz Medical Campus Research Laboratory, Aurora, CO, USA |
||||
|
(211) PROPHYLACTIC OR POST-TRAUMATIC TREATMENT OF HYPOFIBRINOGENEMIA AND DYSFIBRINOGENEMIA WITH FIBRGYA IN EIGHT CLINICAL CASES Jessica N. Mistretta, Kristin T. Ansteatt, Michael D. Tarantino. Bleeding and Clotting Disorder Institute, Peoria, IL, USA |
||||
|
(212) REAL-WORLD USE OF RECOMBINANT FACTOR IX FUSION PROTEIN IN PREVIOUSLY UNTREATED PATIENTS WITH CONGENITAL HEMOPHILIA B FROM THE ATHN 8 STUDY Courtney D. Thornburg1, Martin Chandler2, Lynn Malec3, Matthew Manuel2, Carrie O'Neill2, Michael Recht4, 5, Elizabeth Taggart2, Hongseok Kim6, Vidhi Desai6, Hiren Shah6, Shannon L. Carpenter7. 1Rady Children’s Hospital San Diego, San Diego, CA, USA 2American Thrombosis and Hemostasis Network, Rochester, NY, USA 3Versiti Blood Research Institute, Waukesha, WI, USA 4Yale University School of Medicine, New Haven, CT, USA 5National Bleeding Disorders Foundation, New York, NY, USA 6CSL Behring, King of Prussia, PA, USA 7Children’s Mercy Hospital, Kansas City, MO, USA |
||||
|
(213) THE EFFECT OF BUDD-CHIARI SYNDROME (BCS) IN HOSPITALIZED HEPATOCELLULAR CARCINOMA PATIENTS (HCC): A NATIONWIDE ANALYSIS. Ekrem G Turk, Ayobami Olafimihan, Khaldun Obeidat, Youjin Oh, Lina James, Angelo Caputi Zuniga, Alejandro Vallejo. John H. Stroger, Jr. Hospital of Cook County, Chicago, IL, USA |
|||||
A8. ANTITHROMBOTIC THERAPY | |||||
|
(215) ANTI-FACTOR XI ANTIBODIES TARGETING THE APPLE 2 DOMAIN AND THE CATALYTIC DOMAIN EXERT DISTINCT IN VITRO INHIBITORY PROFILES ON COAGULATION FUNCTION Dan Chalothorn, KehDih Lai, Weizhen Wu, Holly Sorenson, George Ehrlich, Ashique Rafique, Ishita Chatterjee, Kei Saotome, Matthew Franklin, Lori Morton. Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA |
||||
|
(216) ANTITHROMBOSIS STEWARDSHIP AS A KEY DRIVER WITHIN A VTE CENTER OF EXCELLENCE - AMBITION INVESTIGATORS Angela M. Martoccia Grabazs, Preeyaporn Sarangarm, Sundeep S. Guliani, Jonathan L. Marinaro, Allison E. Burnett. University of New Mexico Hospital, Albuquerque, NM, USA |
|||||
|
(217) ANTICOAGULATION STEWARDSHIP: APPROPRIATE USE OF APIXABAN AND RIVAROXABAN FACTOR XA LEVELS IN THE EMERGENCY DEPARTMENT Firas Quran, Sara Zochert, Michael Gulseth, Alicia Martin. Sanford USD Medical Center and Hospital, Sioux Falls, SD, USA |
||||
A9. INFORMATIONAL ABSTRACT (POSTER ONLY) | |||||
|
(218) CELLULAR INDICES OF DVT Priyanka Kavdikar1, Ragini Mohan1, Neha Thomas1,3, Fakiha Siddiqui2, Atul Laddu1, Jawed Fareed2, Nysha Reddy1. 1Global Thrombosis Forum, Suwanee, GA, USA 2Loyola University, Chicago, IL, USA 3University of Westminster, London, United Kingdom |
||||
|
(219) ARE MEDICAL LEARNERS ADEPT AT RECOGNIZING HEAVY VAGINAL BLEEDING? Fartoon M Siad1, Andrea Lausman2, Filomena Meffe2, Carolyn Snider3, Martina Trinkaus1,4, Michelle Sholzberg1,4. 1Department of Medicine, University of Toronto, Toronto, ON, Canada 2Department of Obstetrics and Gynecology, Toronto, ON, Canada 3Division of Emergency Medicine, Toronto, ON, Canada 4Division of Hematology/Oncology, St. Michael’s Hospital, Toronto, ON, Canada |
||||